Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises eDSP, which is in Phase ...
Leadership
Dirk Thye M.D.
CEO, Chief Medical Officer & Director
Charles S. Ryan J.D., Ph.D.
President
Brendan Hannah M.B.A.
Chief Business Officer, COO, Chief Compliance Officer and Principal Financial & Accounting Officer
